Despite an increase in the use of medication for opioid use disorder in older adults from 2017 to 2022, disparities persist; ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

A new rule requires insurers to improve coverage of PrEP, which can prevent HIV, but Georgians face challenges getting the ...

Learn more about whether Merit Medical Systems, Inc. or Omnicell, Inc. is a better investment based on AAII's A+ Investor ...

Approximately half of all Americans do not take their medication as prescribed by their doctor. This medication non-adherence ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

Approximately half of all Americans do not take their medication as prescribed by their doctor. This medication non-adherence causes an estimated ...

New research that published today in JAMA Network Open shows prescription medication subscription models are effective ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Objectives Patients with SLE take multiple medications. Within a large prospective longitudinal SLE cohort, we characterised ...

Adhere+, a telehealth company focused on improving patient outcomes through a SaaS-based telehealth care plan adherence and medication compliance technology platform, today announced the release of ...